Global and domestic brokerage houses shared their latest stock recommendations across consumer, real estate, pharma, logistics, and infrastructure sectors. Analysts largely maintained a positive outlook, with select upgrades in target prices.
Citi maintained buy on Swiggy, raising the target price to ₹495 per share from ₹465 earlier, citing improving profitability and order growth.
Citi also reiterated buy on Eternal, increasing the target price to ₹395 per share from ₹320, expecting margin expansion in coming quarters.
Macquarie maintained outperform on IRCTC with a target of ₹900 per share, highlighting steady demand recovery in travel services.
Morgan Stanley (MS) maintained overweight on Schloss Bangalore, with a target price of ₹562 per share.
Goldman Sachs (GS) reiterated buy on Indigo, valuing the stock at ₹6,000 per share, driven by strong air traffic and robust capacity expansion.
Nomura maintained buy on Prestige Estates with a target price of ₹1,900 per share, supported by sustained momentum in residential sales.
CLSA reiterated outperform on PVR INOX with a target of ₹1,920 per share, expecting steady footfalls and margin recovery.
Citi maintained buy on Lupin, setting a target price of ₹2,260 per share, citing a healthy U.S. pipeline and strong domestic formulations growth.
Jefferies kept buy on Adani Enterprises, with a target price of ₹3,000 per share, noting diversified business catalysts and strong order visibility.
Motilal Oswal (MOSL) maintained buy on Delhivery, with a target price of ₹540 per share, driven by operational efficiency improvements.
Jefferies noted positive trends in the pharma sector, with steady performance among leading generic players; Sun Pharma and Dr Reddy’s were cited as key beneficiaries.
Morgan Stanley on the chemical and energy sector said PSU reforms, strong domestic demand, and China’s “anti-involution” pivot remain key drivers. Top picks include Reliance
Industries, PI Industries, Tata Chemicals, and OMCs.
UBS maintained a neutral stance on ABB India, with a target of ₹5,360 per share, citing near-term valuation constraints.
Nuvama retained buy on Prestige Estates, trimming its target to ₹1,966 per share amid moderate growth expectations.
Disclaimer: This news is for informational purposes only and not investment advice. Brokerage views are their own; investors should consult certified financial advisors before making investment decisions.
